RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

Yes. Excerpt from their PR below, my impression is the new guy was brought in as a closer or deal maker....

"Mr. Clodfelter has extensive experience providing business development, strategy, and valuation
consulting services to pharmaceutical, biotech and medical device companies, where he has led or
been a core member on over 30 international and domestic pharmaceutical licensing and device
negotiations ranging from preclinical to launched products. This experience extends across large
pharmaceutical, biotechnology and medical device companies. He previously held positions at Eli
Lilly and Co. in Corporate Strategy and Business Development. He was at Amylin Pharmaceuticals
in New Product Planning and Decision Sciences and was involved in multiple business
development activities. Following Amylin, Mr. Clodfelter was the Chief Executive Officer of
Medicus Biosciences and Abvance Therapeutics, both biotechnology firms based in California"